Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine.

DJ, Hewitt; SK, Aurora; DW, Dodick; PJ, Goadsby; YJ, Ge; R, Bachman; D, Taraborelli; X, Fan; C, Assaid; C, Lines; TW, Ho

doi:10.1177/0333102411398399

Public

Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine.

Shared by NobleBlocks on Mar 7, 2011 • 12:00 AM UTC

Authors:

Hewitt DJ

Aurora SK

Dodick DW

Abstract

<h4>Background</h4>This study evaluated the CGRP receptor antagonist MK-3207 for acute treatment of migraine.<h4>Methods</h4>Multicenter, double-blind, randomized, placebo-controlled, parallel-group, two-stage adaptive study with two interim efficacy analyses to facilitate optimal dose selection. Mi...

Discussions